Kirkland's 10-Q: Credit Agreements and Financial Update
Ticker: TBHC · Form: 10-Q · Filed: Dec 6, 2024 · CIK: 1056285
| Field | Detail |
|---|---|
| Company | Kirkland'S, INC (TBHC) |
| Form Type | 10-Q |
| Filed Date | Dec 6, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, credit-agreement, financial-reporting
TL;DR
Kirkland's 10-Q shows new credit deals and financial data. Keep an eye on debt.
AI Summary
Kirkland's, Inc. filed a 10-Q for the period ending November 2, 2024. The company reported on its financial performance and disclosed details regarding its credit agreements, including a Beyond Credit Agreement entered into on October 21, 2024, and a Term Loan Credit Agreement dated January 25, 2024. The filing also references retained earnings as of January 29, 2023.
Why It Matters
This filing provides insight into Kirkland's financial health and its debt structure, which can impact its operational flexibility and future investment capabilities.
Risk Assessment
Risk Level: medium — The company's financial performance and debt structure, as detailed in the 10-Q, present potential risks.
Key Numbers
- 2024-11-02 — Reporting Period End Date (Indicates the latest financial data available.)
- 2024-10-21 — Beyond Credit Agreement Date (Marks a significant financing event.)
- 2024-01-25 — Term Loan Credit Agreement Date (Details a key debt instrument.)
Key Players & Entities
- Kirkland's, Inc. (company) — Filer of the 10-Q
- November 2, 2024 (date) — End of reporting period
- October 21, 2024 (date) — Date of Beyond Credit Agreement
- January 25, 2024 (date) — Date of Term Loan Credit Agreement
- January 29, 2023 (date) — Date for retained earnings
FAQ
What are the key terms of the Beyond Credit Agreement dated October 21, 2024?
The filing mentions the 'BeyondCreditAgreementMember' but does not provide specific terms within this snippet.
What is the total amount of retained earnings as of January 29, 2023?
The filing references 'us-gaap:RetainedEarningsMember' as of '2023-01-29' but does not state the specific dollar amount in this snippet.
What is the maturity date of the Term Loan Credit Agreement dated January 25, 2024?
The filing mentions the 'TermLoanCreditAgreementMember' dated '2024-01-25' but does not specify the maturity date in this snippet.
Does Kirkland's, Inc. have any revolving credit facilities?
Yes, the filing mentions 'us-gaap:RevolvingCreditFacilityMember' and 'kirk:CreditAgreementMember' in relation to dates like '2024-01-25'.
What was Kirkland's fiscal year end prior to the period ending November 2, 2024?
The filing indicates a fiscal year end of '0203', suggesting the fiscal year ends around February.
Filing Stats: 4,486 words · 18 min read · ~15 pages · Grade level 16.7 · Accepted 2024-12-06 16:17:23
Filing Documents
- kirk-20241102.htm (10-Q) — 1614KB
- kirk-ex31_1.htm (EX-31.1) — 14KB
- kirk-ex31_2.htm (EX-31.2) — 14KB
- kirk-ex32_1.htm (EX-32.1) — 8KB
- kirk-ex32_2.htm (EX-32.2) — 8KB
- img245230104_0.jpg (GRAPHIC) — 80KB
- 0000950170-24-134116.txt ( ) — 5253KB
- kirk-20241102.xsd (EX-101.SCH) — 646KB
- kirk-20241102_htm.xml (XML) — 607KB
Financial Statements
Financial Statements 3 Condensed Consolidated Balance Sheets (Unaudited) as of November 2, 2024, February 3, 2024, and October 28, 2023 3 Condensed Consolidated Statements of Operations (Unaudited) for the 13-week and 39-week periods ended November 2, 2024 and October 28, 2023 4 Condensed Consolidated Statements of Shareholders' (Deficit) Equity (Unaudited) for the 13-week and 39-week periods ended November 2, 2024 and October 28, 2023 5 Condensed Consolidated Statements of Cash Flows (Unaudited) for the 39-week periods ended November 2, 2024 and October 28, 2023 6 Notes to Condensed Consolidated Financial Statements (Unaudited) 7 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 23 Item 4.
Controls and Procedures
Controls and Procedures 23 PART II OTHER INFORMATION 24 Item 1.
Legal Proceedings
Legal Proceedings 24 Item 1A.
Risk Factors
Risk Factors 24 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25 Item 5. Other Information 25 Item 6. Exhibits 25
SIGNATURES
SIGNATURES 26 2 Table of Contents
- FINANC IAL INFORMATION
PART I - FINANC IAL INFORMATION
FINANC IAL STATEMENTS
ITEM 1. FINANC IAL STATEMENTS KIRKLAND'S, INC. CONDENSED CONSOLIDATED BA LANCE SHEETS (UNAUDITED) (in thousands, except share data) November 2, February 3, October 28, 2024 2024 2023 ASSETS Current assets: Cash and cash equivalents $ 6,756 $ 3,805 $ 5,765 Inventories, net 111,219 74,090 105,190 Prepaid expenses and other current assets 6,494 7,614 5,863 Total current assets 124,469 85,509 116,818 Property and equipment: Equipment 19,067 19,144 19,556 Furniture and fixtures 62,846 63,823 65,302 Leasehold improvements 99,923 100,393 101,925 Computer software and hardware 78,765 78,580 83,236 Projects in progress 526 647 643 Property and equipment, gross 261,127 262,587 270,662 Accumulated depreciation ( 237,289 ) ( 232,882 ) ( 239,014 ) Property and equipment, net 23,838 29,705 31,648 Operating lease right-of-use assets 123,916 126,725 130,513 Other assets 7,591 8,634 6,848 Total assets $ 279,814 $ 250,573 $ 285,827 LIABILITIES AND SHAREHOLDERS' (DEFICIT) EQUITY Current liabilities: Accounts payable $ 61,177 $ 46,010 $ 55,729 Accrued expenses 23,830 23,163 23,484 Operating lease liabilities 38,541 40,018 39,966 Total current liabilities 123,548 109,191 119,179 Operating lease liabilities 99,222 99,772 108,248 Long-term debt, net 80,397 34,000 62,000 Other liabilities 3,779 4,486 3,685 Total liabilities 306,946 247,449 293,112 Shareholders' (deficit) equity: Preferred stock, no par value, 10,000,000 shares authorized; no shares issued or outstanding at November 2, 2024, February 3, 2024, and October 28, 2023, respectively — — — Common stock, no par value; 100,000,000 shares authorized; 13,117,942 ; 12,926,022 ; and 12,923,677 , shares issued and outstanding at November 2, 2024, February 3, 2024, and October 28, 2023, respecti